Physician profile
John E Willard
NPI 1083602452
$1,480.19
in general payments reported to CMS, 2019-2025
16 companies · $60.91 in 2025
The $60.91 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $199 · 2021: $113 · 2022: $191 · 2023: $262 · 2024: $137 · 2025: $60.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $362.52 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $193.18 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $159.17 | 2019-2023 | Farxiga, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $147.95 | 2019-2023 | Camzyos |
| Amgen INC. | $122.65 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $85.32 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.72 | 2019-2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $69.99 | 2022 | |
| Pfizer INC. | $66.87 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.61 | 2019-2023 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $55.64 | 2019 | |
| Abbott Laboratories | $24.83 | 2021 | |
| Abiomed | $17.03 | 2019 | |
| Heartflow, INC. | $16.23 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals International, Plc | $14.48 | 2024 | Arcalyst |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Willard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.